US Stem Cell Inc (USRM)

[MyzStreet]

MESOBLAST, INC. Vs U.S. STEM CELL INC.

95.7 TO 52 BIOHEART MYOCELL BEATS MESOBLAST MPCS IN SIDE BY SIDE PHASE II/III CLINICAL TRIAL PERFORMANCE IN THE PRIMARY END POINT MEASURE OF EXERCISE CAPACITY IMPROVEMENT IN HEART FAILURE PATIENTS VIA 6 MIN. WALK TESTING.

95.7 TO 53 BIOHEART MYOCELL BEATS CARDIO3 C-CURE CARDIAC STEM CELLS IN SIDE BY SIDE COMPARISON – 6 MIN. WALK.

95.7 TO 53 BIOHEART MYOCELL BEATS CAPRICOR CARDIAC STEM CELLS IN SIMILAR CLINICAL STUDIES – 6 MIN. WALK.

http://www.calstockexchange.com/leonhardt-ventures-fall-2012-newsletter/


MESO trading at $10.97 pps

Outstanding Shares 381,654,048

https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11065110



USRM Security Details .099 pps
Lolololol

Outstanding Shares 325,765,048 a/o Mar 15, 2017

https://www.otcmarkets.com/stock/USRM/quote